USPTO serial 79140680
DNAVEC CORPORATION
Reviewed by CopyMark Law Group
Reg. 4680265Status 404
- Filing date
- Status date
- Registration date
- Feb 3, 2015
- Examiner
- PAQUIN, SAMUEL ROBERT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DNAVEC CORPORATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Corey K. Cho
Corey K. Cho Saliwanchik, Lloyd & Eisenschenk, P.A.P.O. Box 142950Gainesville, FL 32614-2950UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals | SECTION 70 - CANCELLED | — |
| 005 | Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDs, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical purposes; vaccines; gene vaccines; RNA vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical use, namely, for gene therapy | SECTION 70 - CANCELLED | — |
| 042 | Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science; testing or research on machines and instruments; computer software design, computer programming, or maintenance of computer software; rental of computers and rental of computer programs | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DNAVEC CORPORATION
- Other trademarks owned by DNAVEC CORPORATION
- Other trademarks owned by ID Pharma Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named DNAVEC CORPORATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 4, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 1, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 11, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 12, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 4, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 4, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 3, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 3, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 18, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 18, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 14, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 29, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 29, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 29, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 1, 2014 | ALIE | ASSIGNED TO LIE | — |
| Sep 19, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 9, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 29, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 29, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 18, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 28, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 6, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 6, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 6, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 5, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 31, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 30, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 28, 2013 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |